| Year |
Citation |
Score |
| 2021 |
Kaspi H, Semo J, Abramov N, Dekel C, Lindborg S, Kern R, Lebovits C, Aricha R. MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model. Stem Cell Research & Therapy. 12: 72. PMID 33468250 DOI: 10.1186/s13287-021-02143-w |
0.702 |
|
| 2020 |
Kern R, Aricha R, Kaspi H, Gothelf Y, Lebovits C. Effects of MSC-NTF cells on T and B regulatory cell function in ALS. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 21: 638-639. PMID 32808546 DOI: 10.1080/21678421.2020.1800747 |
0.72 |
|
| 2019 |
Berry JD, Cudkowicz ME, Windebank AJ, Staff NP, Owegi M, Nicholson K, McKenna-Yasek D, Levy YS, Abramov N, Kaspi H, Mehra M, Aricha R, Gothelf Y, Brown RH. NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results. Neurology. PMID 31740545 DOI: 10.1212/Wnl.0000000000008620 |
0.708 |
|
| 2017 |
Gothelf Y, Kaspi H, Abramov N, Aricha R. miRNA profiling of NurOwn®: mesenchymal stem cells secreting neurotrophic factors. Stem Cell Research & Therapy. 8: 249. PMID 29116031 DOI: 10.1186/s13287-017-0692-1 |
0.695 |
|
| 2015 |
Nathan G, Kredo-Russo S, Geiger T, Lenz A, Kaspi H, Hornstein E, Efrat S. MiR-375 promotes redifferentiation of adult human β cells expanded in vitro. Plos One. 10: e0122108. PMID 25875172 DOI: 10.1371/Journal.Pone.0122108 |
0.672 |
|
| 2014 |
Kaspi H, Pasvolsky R, Hornstein E. Could microRNAs contribute to the maintenance of β cell identity? Trends in Endocrinology and Metabolism: Tem. 25: 285-92. PMID 24656914 DOI: 10.1016/J.Tem.2014.01.003 |
0.711 |
|
| 2013 |
Kaspi H, Chapnik E, Levy M, Beck G, Hornstein E, Soen Y. Brief report: miR-290-295 regulate embryonic stem cell differentiation propensities by repressing Pax6. Stem Cells (Dayton, Ohio). 31: 2266-72. PMID 23843298 DOI: 10.1002/Stem.1465 |
0.652 |
|
| Show low-probability matches. |